Search Results

There are 12792 results for: content related to: Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

  1. You have free access to this content
    Effects of anti-tumour necrosis factor-α therapy on the quality of life in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 6, June 2002, Pages: 1101–1107, B. P. J. Van Balkom, E. J. Schoon, R. W. Stockbrügger, F. L. Wolters, R. A. Van Hogezand, S. J. H. Van Deventer, B. Oldenburg, H. M. Van Dullemen and M. G. V. M. Russel

    Article first published online : 27 MAY 2002, DOI: 10.1046/j.1365-2036.2002.01268.x

  2. You have free access to this content
    An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 6, June 2002, Pages: 1117–1124, J. M. Sabate, J. Villarejo, M. Lemann, J. Bonnet, M. Allez and R. Modigliani

    Article first published online : 27 MAY 2002, DOI: 10.1046/j.1365-2036.2002.01273.x

  3. You have free access to this content
    Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 7, October 2005, Pages: 613–626, T. HLAVATY, M. PIERIK, L. HENCKAERTS, M. FERRANTE, S. JOOSSENS, N. VAN SCHUERBEEK, M. NOMAN, P. RUTGEERTS and S. VERMEIRE

    Article first published online : 23 SEP 2005, DOI: 10.1111/j.1365-2036.2005.02635.x

  4. You have free access to this content
    Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 12, June 2008, Pages: 1210–1223, F. TINÈ, F. ROSSI, A. SFERRAZZA, A. ORLANDO, F. MOCCIARO, D. SCIMECA, M. OLIVO and M. COTTONE

    Article first published online : 14 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03681.x

  5. You have free access to this content
    Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease – modelling outcomes in active luminal and fistulizing disease in adults

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 1, July 2008, Pages: 76–87, J. LINDSAY, Y. S. PUNEKAR, J. MORRIS and G. CHUNG-FAYE

    Article first published online : 11 APR 2008, DOI: 10.1111/j.1365-2036.2008.03709.x

  6. You have free access to this content
    Fistula response to methotrexate in Crohn's disease: a case series

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 1003–1008, U. Mahadevan, J. F. Marion and D. H. Present

    Article first published online : 14 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01790.x

  7. You have free access to this content
    Review article: medical therapy for fistulizing Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 9, November 2006, Pages: 1283–1293, B. BRESSLER and B. E. SANDS

    Article first published online : 16 OCT 2006, DOI: 10.1111/j.1365-2036.2006.03126.x

  8. You have free access to this content
    Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 5, March 2004, Pages: 511–519, E. Louis, Z. El Ghoul, S. Vermeire, S. Dall'Ozzo, P. Rutgeerts, G. Paintaud, J. Belaiche, M. De Vos, A. Van Gossum, J. -F. Colombel and H. Watier

    Article first published online : 19 FEB 2004, DOI: 10.1111/j.1365-2036.2004.01871.x

  9. You have free access to this content
    Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 9, May 2004, Pages: 1019–1024, A. Di Sabatino, R. Ciccocioppo, L. Benazzato, G. C. Sturniolo and G. R. Corazza

    Article first published online : 6 APR 2004, DOI: 10.1111/j.1365-2036.2004.01927.x

  10. You have free access to this content
    Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue 5, September 2004, Pages: 585–592, Q. Gao, R. A. van Hogezand, C. B. H. W. Lamers and H. W. Verspaget

    Article first published online : 16 AUG 2004, DOI: 10.1111/j.1365-2036.2004.02126.x

  11. You have free access to this content
    Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 6, September 2008, Pages: 674–688, R. PANACCIONE, P. RUTGEERTS, W. J. SANDBORN, B. FEAGAN, S. SCHREIBER and S. GHOSH

    Article first published online : 3 JUN 2008, DOI: 10.1111/j.1365-2036.2008.03753.x

  12. You have free access to this content
    Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn’s fistulas

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 7, October 2009, Pages: 757–766, S. C. NG, S. PLAMONDON, A. GUPTA, D. BURLING and M. A. KAMM

    Article first published online : 3 JUL 2009, DOI: 10.1111/j.1365-2036.2009.04088.x

  13. You have free access to this content
    Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 5, March 2007, Pages: 557–567, S. PLAMONDON, S. C. NG and M. A. KAMM

    Article first published online : 8 JAN 2007, DOI: 10.1111/j.1365-2036.2006.03239.x

  14. You have free access to this content
    The medical treatment of Crohn's perianal fistulas

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 9, May 2004, Pages: 953–967, D. A. Schwartz and C. R. Herdman

    Article first published online : 19 APR 2004, DOI: 10.1111/j.1365-2036.2004.01917.x

  15. You have free access to this content
    Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease – subgroup results from a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 2, January 2011, Pages: 185–193, S. Schreiber, I. C. Lawrance, O. Ø. Thomsen, S. B. Hanauer, R. Bloomfield and W. J. Sandborn

    Article first published online : 17 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04509.x

  16. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Article first published online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  17. You have free access to this content
    Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1007–1016, V. Pittet, P. Juillerat, P. Michetti, J.-P. Vader, B. Burnand, G. Rogler, C. Beglinger, F. Seibold, C. Mottet, C. Felley, J.-J. Gonvers, F. Froehlich and The Swiss IBD Cohort Study Group

    Article first published online : 18 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04434.x

  18. You have free access to this content
    Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 7, October 2009, Pages: 749–756, G. BOUGUEN, I. TROUILLOUD, L. SIPROUDHIS, A. OUSSALAH, M.-A. BIGARD, J.-F. BRETAGNE and L. PEYRIN-BIROULET

    Article first published online : 6 JUL 2009, DOI: 10.1111/j.1365-2036.2009.04089.x

  19. You have free access to this content
    Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 11-12, December 2007, Pages: 1509–1520, G. G. KAPLAN, C. HUR, J. KORZENIK and B. E. SANDS

    Article first published online : 11 OCT 2007, DOI: 10.1111/j.1365-2036.2007.03548.x

  20. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 8, August 2007, Pages: 1306–1312, Peter R Gibson, Adèle R Weston, Amelia Shann, Timothy H J Florin, Ian C Lawrance, Finlay A Macrae and Graham Radford-Smith

    Article first published online : 7 JUN 2007, DOI: 10.1111/j.1440-1746.2007.04930.x